Adjusted Gapss Antiphospholipid Syndrome Risk
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- High risk≥ 10
- Moderate risk≥ 6
- Lower risk≥ 0
The Adjusted Gapss Antiphospholipid Syndrome Risk calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include acl. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Adjusted GAPSS: thrombotic risk in antiphospholipid syndrome.
Clinical Indication
The Adjusted Gapss Antiphospholipid Syndrome Risk is indicated for bedside clinical practice to support Adjusted GAPSS: thrombotic risk in antiphospholipid syndrome.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention. Clinical exclusion: Adjusted GAPSS excludes anti-phosphatidylserine/prothrombin..
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.
aCL 5 + anti-b2GP1 4 + LA 4 + hyperlipidemia 3 + hypertension 1; total 0-17.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| acl | string | Yes | Anticardiolipin antibodies: yes, no |
| anti_b2gp1 | string | Yes | Anti-beta2-glycoprotein I: yes, no |
| lupus_anticoagulant | string | Yes | Lupus anticoagulant: yes, no |
| hyperlipidemia | string | Yes | Hyperlipidemia: yes, no |
| hypertension | string | Yes | Arterial hypertension: yes, no |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 10 | High risk | High thrombotic risk |
| ≥ 6 | Moderate risk | Moderate risk |
| ≥ 0 | Lower risk | Lower risk |
Evidence-Based References (EBM)
- Sciascia S, Sanna G, Murru V, et al. GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology. 2013;52(8):1397-1403.